Essity AB stock (SE0009922164): hygiene group updates strategy amid margin focus

Essity AB, the Swedish hygiene and health group behind TENA and other tissue brands, is sharpening its portfolio and efficiency measures as it pursues margin improvement after recent strategic steps and a completed listing change in Stockholm.

Essity AB, the global hygiene and health company best known for brands such as TENA and Tork, remains in a strategic transition phase as it focuses on profitability, portfolio streamlining and efficiency gains after recent portfolio measures and structural changes reported over the past quarters, according to Essity’s latest investor information and recent company presentations.

As of: 09.06.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Essity B
• Sector/industry: Hygiene and health products (tissue, incontinence care, personal care)
• Headquarters/country: Stockholm, Sweden
• Core markets: Europe, North America, Latin America and Asia
• Key revenue drivers: Tissue products, incontinence products, professional hygiene solutions and consumer tissue
• Home exchange/listing venue: Nasdaq Stockholm (ticker: ESSITY B)
• Trading currency: Swedish krona (SEK)

Essity AB: core business model

Essity AB operates a global hygiene and health business built around three main pillars: incontinence products, professional hygiene and consumer tissue. The group focuses on branded products that are used daily by private households, institutions and companies, ranging from adult incontinence pads to paper towels in public restrooms and household toilet paper. This everyday-use profile makes revenue comparatively recurring, as products are consumed quickly and need regular replenishment.

The company positions itself as a leader in incontinence care with its TENA brand, which targets both retail customers and institutional care providers. In professional hygiene, Essity serves offices, hospitals, restaurants, industrial sites and public facilities through its Tork brand, which provides dispensers, paper towels, tissue rolls and related services. The consumer tissue segment covers branded toilet paper, kitchen towels, handkerchiefs and napkins that are sold through major retail chains and supermarkets in many markets.

Essity’s business model combines high product volumes with an extensive manufacturing and distribution footprint. The company runs tissue mills, converting plants and packaging facilities in numerous countries to reduce logistics costs and to adapt products to regional preferences. Scale is crucial in the tissue and hygiene industry, because production lines are capital-intensive and raw materials such as pulp and recycled fiber contribute significantly to the cost base. Essity aims to leverage its scale to optimize sourcing, production and distribution economics.

At the same time, the company emphasizes product differentiation through brand building, innovation and partnerships with healthcare providers and institutions. In incontinence care, for example, Essity invests in product design, skin-friendly materials and discrete packaging to reduce stigma and improve comfort for users. In professional hygiene, the group offers digital tools and services around its Tork brand that help facility managers optimize refill cycles and reduce waste. This mix of commodity-like volumes and branded solutions is central to Essity’s competitive positioning.

Sustainability is another important element of the business model. The company publicly highlights efforts to use certified or recycled fibers, increase energy efficiency in production and reduce emissions over time. In the hygiene sector, sustainability is closely linked to regulatory and consumer pressure, particularly in Europe and North America, where retailers and end customers increasingly scrutinize the environmental footprint of tissue products and packaging. For Essity, investments in more efficient technologies and alternative materials are therefore both a cost and a potential differentiation factor.

Main revenue and product drivers for Essity AB

Essity’s revenue is driven primarily by demand for tissue and hygiene products in Europe and North America, complemented by growth markets in Latin America and parts of Asia. The company participates in underlying demographic and structural trends such as aging populations, urbanization and rising hygiene standards. An aging demographic tends to support demand for incontinence products, while urbanization and higher incomes increase consumption of tissue and personal care products in emerging markets.

Within the portfolio, incontinence care is typically positioned as a higher-margin category than basic tissue. Products such as adult diapers, pads and related solutions are less commoditized, because brand trust, product performance and relationships with healthcare institutions play a larger role in purchasing decisions. For Essity, this segment offers room for innovation in fit, absorption, discretion and digital support services, which can help justify premium pricing and support margin resilience even when raw material costs fluctuate.

Professional hygiene is another key driver, as it ties Essity’s business to economic activity in offices, restaurants, hotels, airports and other public venues. Demand in this segment can fluctuate with macroeconomic cycles and mobility trends, but the underlying need for hygiene in public and commercial spaces is structurally stable. Over the past years, heightened awareness of hygiene in public places has further underscored the importance of reliable supplies of paper towels, tissues and soap dispensers for institutions.

Consumer tissue remains a large, volume-driven business for Essity. Here, competition is intense, with private labels and other branded players competing for shelf space in supermarkets and discounters. To protect its position, Essity invests in maintaining brand recognition, adapting packaging and format sizes to different retail channels and offering promotional campaigns. Pricing in consumer tissue is a central lever to offset swings in pulp and energy prices, but aggressive price increases carry the risk of volume pushback in price-sensitive segments.

Raw material costs play a major role in Essity’s profitability. Pulp, recycled fiber, energy and transportation costs have all experienced phases of significant volatility in recent years. When costs rise quickly, margins can come under pressure if price adjustments in the marketplace lag behind. Conversely, when input costs ease, Essity can benefit from margin relief if it holds on to price levels. This dynamic makes the company’s procurement strategy and hedging policies important drivers of earnings over the cycle.

Currency effects also influence Essity’s reported numbers, as the group earns revenue in a wide range of currencies but reports in Swedish krona. Exchange rate movements, particularly against the euro and the US dollar, can affect both the translation of foreign earnings and the competitiveness of exports. For US investors looking at Essity’s Stockholm listing or at any depository receipts, currency exposure is therefore a factor to consider when interpreting historical performance and potential future returns in US dollars.

Conclusion

Essity AB combines a defensive demand profile in hygiene and health with the cyclicality of raw material and energy costs. The company’s focus on incontinence care, professional hygiene and branded consumer tissue ties it to demographic trends and everyday consumption. At the same time, profitability depends on how effectively Essity manages input cost volatility, pricing and efficiency measures across its global production network. For US investors, the Stockholm listing and Swedish krona reporting introduce currency considerations on top of the underlying business performance. Overall, Essity’s strategic emphasis on higher-value hygiene segments, sustainability and operational discipline illustrates how a traditional tissue producer is positioning itself as a broader hygiene and health group in an evolving global market.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.